1. 1605PDHealth-related quality of life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first line. (23rd October 2018) Authors: Grünwald, V; Schuler, M; Schöffski, P; Kopp, H-G; Bauer, S; Kasper, B; Lindner, L H; Chemnitz, J M; Crysandt, M; Stein, A; Steffen, B; Richter, S; Kneba, M; Egerer, G; Zimmermann, S; Karch, A; Kunitz, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1606PDQuality of life in patients with soft tissue sarcoma undergoing palliative treatment: A multicenter, cluster-randomized trial within the Germany Interdisciplinary Sarcoma Group (GISG-12). (23rd October 2018) Authors: Hentschel, L; Richter, S; Kopp, H-G; Kasper, B; Kunitz, A; Grünwald, V; Kessler, T; Chemnitz, J-M; Pelzer, U; Schuler, U S; Freitag, J; Schilling, A; Hornemann, B; Arndt, K; Ehninger, G; Bornhäuser, M; Schuler, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1715PSoft tissue sarcomas express a distinct mRNA immune profile. (1st October 2019) Authors: Grünwald, V; Laenger, F; Kunitz, A; Schuler, M; Schoeffski, P; Kopp, H-G; Bauer, S; Kasper, B; Lindner, L; Chemnitz, J M; Crysandt, M; Stein, A; Steffen, B; Kneba, M; Egerer, G; Zimmermann, S; Ivanyi, P; Karch, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 840PPrognostic value of free testosterone (FT) levels during salvage chemotherapy with carboplatin plus weekly docetaxel in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC). (23rd October 2018) Authors: Reuter, C W M; Brunotte, S; Ivanyi, P; Morgan, M A; Grünwald, V Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 875PCharacterization of response to nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (Pts) with previously untreated advanced renal cell carcinoma (arcc): Checkmate 214. (23rd October 2018) Authors: Rini, B I; Tannir, N M; Escudier, B; McDermott, D F; Grimm, M-O; Porta, C; Powles, T; Kollmannsberger, C K; Gurney, H P; Tykodi, S S; Harrison, M; Heng, D Y C; Grünwald, V; Choueiri, T K; Mekan, S; McHenry, M B; Hammers, H J; Motzer, R J; George, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'. (5th May 2018) Authors: Schöffski, P; Wozniak, A; Stacchiotti, S; Rutkowski, P; Blay, J -Y; Lindner, L H; Strauss, S J; Anthoney, A; Duffaud, F; Richter, S; Grünwald, V; Leahy, M G; Reichardt, P; Sufliarsky, J; van der Graaf, W T; Sciot, R; Debiec-Rychter, M; van Cann, T; Marréaud, S; Lia, M Journal: Annals of oncology Issue: Volume 30:Number 2(2019) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (21st February 2019) Authors: Escudier, B; Porta, C; Schmidinger, M; Rioux-Leclercq, N; Bex, A; Khoo, V; Grünwald, V; Gillessen, S; Horwich, A Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma. Issue 9 (September 2013) Authors: Stenner-Liewen, F; Grünwald, V; Greil, R; Porta, C Journal: Expert review of anticancer therapy Issue: Volume 13:Issue 9(2013) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma. Issue 9 (September 2013) Authors: Stenner-Liewen, F; Grünwald, V; Greil, R; Porta, C Journal: Expert review of anticancer therapy Issue: Volume 13:Issue 9(2013) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗